Surprisingly, the antidepressant fluoxetine inhibits sphingomyelin phosphodiesterase 1 (SMPD1), the key enzyme for sphingolipid biosynthesis, and tumor progression in patient-derived GBM orthotopic xenograft models [55]. This evidence concerns the gene SMPD1 and glioblastoma.